Strides Arcolab reports 97% fall in Q3 net profit

02 Feb 2015 Evaluate

Strides Arcolab has reported results for third quarter ended December 31, 2014.

The company has registered a fall of 97.24% in its net profit after tax at Rs 97.40 crore for the quarter under review as compared to Rs 3525.24 crore for the same quarter in the previous year. However, total income of the company has increased 7.08% at Rs 288.21 crore for Q3FY15 as compared Rs 269.16 crore for the corresponding quarter previous year.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×